货号:A789113
同义名:
2-氨基-4-巯基丁酸
/ NSC 206252; DL-Homocysteine
H-DL-HoCys-OH是一种神经毒素,能够影响犬尿酸的产生,进而影响认知功能和脑白质结构。它在研究神经系统疾病及相关代谢失调中具有应用前景。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | mTOR ↓ ↑ | mTORC1 ↓ ↑ | mTORC2 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AZD-8055 |
++++
mTOR (full length), IC50: 0.8 nM mTOR (truncated), IC50: 0.13 nM |
99%+ | |||||||||||||||||
| Gedatolisib |
++++
mTOR, IC50: 1.6 nM |
99% | |||||||||||||||||
| GSK1059615 |
++
mTOR, IC50: 12 nM |
98% | |||||||||||||||||
| Vistusertib |
+++
mTOR, IC50: 2.8 nM |
99%+ | |||||||||||||||||
| Torin 1 |
+++
mTOR, IC50: 4.32 nM |
+++
mTORC1, IC50: 2 nM |
++
mTORC2, IC50: 10 nM |
DNA-PK | 99%+ | ||||||||||||||
| Dactolisib |
+++
mTOR (p70S6K), IC50: 6 nM |
98+% | |||||||||||||||||
| PI-103 |
+
mTOR, IC50: 30 nM |
99%+ | |||||||||||||||||
| WAY-600 |
++
mTOR, IC50: 9 nM |
99% | |||||||||||||||||
| Voxtalisib |
+
mTOR, IC50: 157 nM |
99%+ | |||||||||||||||||
| PF-04691502 |
++
mTOR, Ki: 16 nM |
98+% | |||||||||||||||||
| Onatasertib |
++
mTOR, IC50: 16 nM |
DNA-PK | 99%+ | ||||||||||||||||
| Chrysophanol | ✔ | EGFR | 98% | ||||||||||||||||
| Samotolisib | ✔ | DNA-PK | 99%+ | ||||||||||||||||
| Torkinib |
+++
mTOR, IC50: 8 nM |
DNA-PK,PDGFR | 99%+ | ||||||||||||||||
| Everolimus | 99%+ | ||||||||||||||||||
| WYE-354 |
+++
mTOR, IC50: 5 nM |
98% | |||||||||||||||||
| Tacrolimus | ✔ | 98% | |||||||||||||||||
| PP121 |
++
mTOR, IC50: 13 nM |
VEGFR,PDGFR | 99%+ | ||||||||||||||||
| Torin 2 |
++++
mTOR, IC50: 0.25 nM |
DNA-PK | 99%+ | ||||||||||||||||
| Rapamycin |
++++
mTOR, IC50: ~0.1 nM |
98% | |||||||||||||||||
| GDC-0349 |
+++
mTOR, Ki: 3.8 nM |
98% | |||||||||||||||||
| XL388 |
++
mTOR, IC50: 9.9 nM |
+++
mTORC1, IC50: 8 nM |
+
mTORC2, IC50: 166 nM |
99%+ | |||||||||||||||
| WYE-687 |
+++
mTOR, IC50: 7 nM |
98% | |||||||||||||||||
| Apitolisib |
+
mTOR, Ki app: 17 nM |
98%+ | |||||||||||||||||
| WYE-132 |
++++
mTOR, IC50: 0.19 nM |
99%+ | |||||||||||||||||
| Sapanisertib |
++++
mTOR, Ki: 1.4 nM |
99%+ | |||||||||||||||||
| BGT226 maleate | ✔ | 99%+ | |||||||||||||||||
| ETP-46464 |
++++
mTOR, IC50: 0.6 nM |
DNA-PK | 98% | ||||||||||||||||
| PI3K-IN-1 |
+
mTOR, IC50: 157 nM |
98+% | |||||||||||||||||
| Zotarolimus |
+++
FKBP-12, IC50: 2.8 nM |
98% | |||||||||||||||||
| OSI-027 |
+++
mTOR, IC50: 4 nM |
+
mTORC1, IC50: 22 nM |
+
mTORC2, IC50: 65 nM |
99%+ | |||||||||||||||
| Ridaforolimus |
++++
mTOR, IC50: 0.2 nM |
99%+ | |||||||||||||||||
| Temsirolimus |
+
mTOR, IC50: 1.76 μM |
95% | |||||||||||||||||
| CZ415 |
++
mTOR, pIC50: 8.07 |
99%+ | |||||||||||||||||
| SF2523 |
+
mTOR, IC50: 280 nM |
DNA-PK | 99%+ | ||||||||||||||||
| KU-0063794 |
++
mTORC1, IC50: ~10 nM |
++
mTORC2, IC50: ~10 nM |
99%+ | ||||||||||||||||
| Omipalisib |
++++
mTORC1, Ki: 0.18 nM |
++++
mTORC2, Ki: 0.3 nM |
99%+ | ||||||||||||||||
| Palomid 529 | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| Concentration | Treated Time | Description | References | |
| Neuro 2A (N2A) cells | 50 µM | 24 hours | To investigate the effect of Hcy on 5LO expression levels and its DNA methylation, results showed that Hcy exposure led to a significant increase in 5LO protein and mRNA levels, accompanied by elevated SAH and reduced SAM levels | Aging Cell. 2017 Apr;16(2):273-280. |
| Administration | Dosage | Frequency | Description | References | ||
| ApoE-/- mice | Hyperhomocysteinemia-accelerated atherosclerosis model | Oral administration via drinking water | 1.8 g/L | 8 weeks | To investigate the effects of aerobic exercise and folate supplementation on plasma Hcy level and atherosclerosis development. Results showed that DL-Hcy significantly increased plasma Hcy concentration, while aerobic exercise and folate supplementation reduced Hcy levels and decreased atherosclerotic plaque area. | Acta Cardiol Sin. 2023 Mar;39(2):309-318 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
7.40mL 1.48mL 0.74mL |
36.99mL 7.40mL 3.70mL |
73.98mL 14.80mL 7.40mL |
|
| CAS号 | 454-29-5 |
| 分子式 | C4H9NO2S |
| 分子量 | 135.18 |
| SMILES Code | O=C(O)C(N)CCS |
| MDL No. | MFCD00004898 |
| 别名 | 2-氨基-4-巯基丁酸 ;NSC 206252; DL-Homocysteine |
| 运输 | 蓝冰 |
| InChI Key | FFFHZYDWPBMWHY-UHFFFAOYSA-N |
| Pubchem ID | 778 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
H2O: 40 mg/mL(295.89 mM),配合低频超声助溶 |
沪公网安备 31011702889066号
沪ICP备2024050318号-1